Amy Hannington
Impact in
- Infectious Diseases top 1%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
-
- Antibiotic Use and Resistance
Papers in
-
- COVID-19 Clinical Research Studies 10
-
- Pneumonia and Respiratory Infections 2
- Co-authors
- Kevin Marsh (2 shared papers)J. Anthony G. Scott (2 shared papers)Derrick W. Crook (1 shared paper)David Griffiths (1 shared paper)Brett S Lowe (1 shared paper)
- Journals
- The Lancet (6 papers)Clinical Infectious Diseases (2 papers)EClinicalMedicine (1 paper)Nature Communications (1 paper)The Lancet Infectious Diseases (1 paper)
- Partner nations
- United KingdomKenyaVietnam
In The Last Decade
Amy Hannington
13 papers receiving 1.7k citations
Amy Hannington's Hit Papers
Peers
Comparison fields: 5 of 87
- Infectious Diseases 1.3k
- Applied Microbiology and Biotechnology 37
- Internal Medicine 27
- Epidemiology 130
- Statistics and Probability 47
Countries citing papers authored by Amy Hannington
This map shows the geographic impact of Amy Hannington's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy Hannington with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy Hannington more than expected).
Fields of papers citing papers by Amy Hannington
This network shows the impact of papers produced by Amy Hannington. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy Hannington. The network helps show where Amy Hannington may publish in the future.
Co-authors
The 5 scholars most cited alongside Amy Hannington, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2021 | 411 |
| 2 | Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial Hit paper breakdown → | 2021 | 393 |
| 3 | Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2022 | 282 |
| 4 | Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis Hit paper breakdown → | 2022 | 231 |
| 5 | 2021 | 213 | |
| 6 | Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2023 | 84 |
| 7 | 1998 | 55 | |
| 8 | 1999 | 25 | |
| 9 | 2023 | 25 | |
| 10 | 2024 | 24 | |
| 11 | 2024 | 6 | |
| 12 | 2025 | 5 | |
| 13 | 2025 | 2 |
About Amy Hannington
Amy Hannington is a scholar working on Infectious Diseases, Epidemiology, Surgery, Nuclear Energy and Engineering and Waste Management and Disposal, having authored 13 papers that have together received 1.8k indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (10 papers), Pneumonia and Respiratory Infections (2 papers) and Kawasaki Disease and Coronary Complications (1 paper). The work is most often cited by research in Infectious Diseases (1.3k citations), Applied Microbiology and Biotechnology (37 citations), Internal Medicine (27 citations), Epidemiology (130 citations) and Statistics and Probability (47 citations). Amy Hannington has collaborated with scholars based in United Kingdom, Kenya and Vietnam. Frequent co-authors include Kevin Marsh, J. Anthony G. Scott, Derrick W. Crook, David Griffiths and Brett S Lowe. Their work appears in journals such as The Lancet, Clinical Infectious Diseases, EClinicalMedicine, Nature Communications and The Lancet Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.